Pancreatic Cancer Research

ResearcherUniversity of Kansas Medical CenterActive in the last 2 years

Bailey A. Bye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7278-3927; OpenAlex author ID A5022466395. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 6

  1. DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. Co-author DOI 10.1038/s41598-025-12967-8↗
  2. Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer. Co-author DOI 10.1136/jitc-2024-010057↗
  3. Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. Co-author DOI 10.3390/cancers17071152↗
  4. SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. Co-author DOI 10.1007/s12079-022-00691-1↗
  5. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04572-8↗
  6. Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04615-0↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Nathan VanSaun · 6 shared papers, 2022–2025 · strength 1.21
  2. R. McKinnon Walsh · 5 shared papers, 2022–2025 · strength 1.03
  3. Appolinaire A. Olou · 5 shared papers, 2022–2025 · strength 0.98
  4. Mariana T. Ruckert · 5 shared papers, 2022–2025 · strength 0.94
  5. Sharon Manley · 2 shared papers, 2022 · strength 0.29
  6. Shrikant Anant · 2 shared papers, 2022 · strength 0.29
  7. Emily L. Lasse Opsahl · 1 shared paper, 2025 · strength 0.23
  8. Marina Pasca di Magliano · 1 shared paper, 2025 · strength 0.23
  9. Jiaqi Shi · 1 shared paper, 2025 · strength 0.23
  10. Vanessa S. Silveira · 1 shared paper, 2025 · strength 0.23
  11. Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.23
  12. Filip Bednar · 1 shared paper, 2025 · strength 0.23
  13. Prasad R. Dandawate · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.